Update of secondary stroke prevention
Author(s) -
H.C. Diener,
Christian Weimar
Publication year - 2009
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/gfp068
Subject(s) - medicine , stroke (engine) , antithrombotic , concomitant , stenosis , cardiology , vascular disease , secondary prevention , risk factor , disease , surgery , mechanical engineering , engineering
Secondary prevention aims at preventing a stroke after a transient ischaemic attack (TIA) or a recurrent stroke after a first stroke. About 80–85% of patients survive a first ischaemic stroke [1,2]. Of those, between 8 and 15% suffer a recurrent stroke in the first year. The risk of stroke recurrence is highest in the first few weeks and declines over time [3–5]. The risk of recurrence depends on concomitant vascular diseases (coronary heart disease = CHD, peripheral arterial disease = PAD) and vascular risk factors and can be estimated by risk models [6–8]. Stroke risk after a TIA is highest in the first 3 days [9]. Therefore, immediate evaluation of patients with a stroke or TIA, identification of the pathophysiology and initiation of secondary prevention are of major importance [10]. In the following sections, we will deal with the treatment of risk factors, antithrombotic therapy and surgery or stenting of significant stenosis of extracranial arteries.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom